Analystreport

Adverum Biotechnologies (NASDAQ:ADVM) was given a new $4.00 price target on by analysts at Royal Bank Of Canada.

Adverum Biotechnologies, Inc.  (ADVM) 
Last adverum biotechnologies, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: adverum.gcs-web.com/investor-overview